{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:21:09Z","timestamp":1790796069350,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL006168"],"award-info":[{"award-number":["HL006168"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL006225"],"award-info":[{"award-number":["HL006225"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["Coleman Award"],"award-info":[{"award-number":["Coleman Award"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["Social Determinants of Obesity"],"award-info":[{"award-number":["Social Determinants of Obesity"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["Cardiovascular Risk Lab Funding"],"award-info":[{"award-number":["Cardiovascular Risk Lab Funding"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiovascular disease (CVD) is the leading cause of death in the world. Given the role of immune cells in atherosclerosis development and progression, effective methods for characterizing immune cell populations are needed, particularly among populations disproportionately at risk for CVD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>By using a variety of antibodies combined in one staining protocol, we were able to identify granulocyte, lymphocyte, and monocyte sub-populations by CD-antigen expression from 500 \u00b5l of whole blood, enabling a more extensive comparison than what is possible with a complete blood count and differential (CBC). The flow cytometry panel was established and tested in a total of 29 healthy men and women. As a proof of principle, these 29 samples were split by their race\/ethnicity: African-Americans (AA) (N\u2009=\u200914) and Caucasians (N\u2009=\u200915). We found in accordance with the literature that AA had fewer granulocytes and more lymphocytes when compared to Caucasians, though the proportion of total monocytes was similar in both groups. Several new differences between AA and Caucasians were noted that had not been previously described. For example, AA had a greater proportion of platelet adhesion on non-classical monocytes when compared to Caucasians, a cell-to-cell interaction described as crucially important in CVD. We also examined our flow panel in a clinical population of AA women with known CVD risk factors (N\u2009=\u200920). Several of the flow cytometry parameters that cannot be measured with the CBC displayed correlations with clinical CVD risk markers. For instance, Framingham Risk Score (FRS) calculated for each participant correlated with immune cell platelet aggregates (PA) (e.g. T cell PA \u03b2\u2009=\u20090.59, p\u2009=\u20090.03 or non-classical monocyte PA \u03b2\u2009=\u20090.54, p\u2009=\u20090.02) after adjustment for body mass index (BMI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A flow cytometry panel identified differences in granulocytes, monocytes, and lymphocytes between AA and Caucasians which may contribute to increased CVD risk in AA. Moreover, this flow panel identifies immune cell sub-populations and platelet aggregates associated with CVD risk. This flow cytometry panel may serve as an effective method for phenotyping immune cell populations involved in the development and progression of CVD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-020-02207-0","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T10:02:59Z","timestamp":1579255379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study"],"prefix":"10.1186","volume":"18","author":[{"given":"Yvonne","family":"Baumer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian A.","family":"Gutierrez-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep K.","family":"Dagur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Langerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joniqua N.","family":"Ceasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy S.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Playford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K. E.","family":"Bleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Philip","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-4131","authenticated-orcid":false,"given":"Tiffany M.","family":"Powell-Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"2207_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146\u2013603.","journal-title":"Circulation"},{"key":"2207_CR2","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","volume":"136","author":"MR Carnethon","year":"2017","unstructured":"Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA Jr, Willis M, et al. Cardiovascular Health in African Americans: a Scientific Statement From the American Heart Association. Circulation. 2017;136:e393\u2013423.","journal-title":"Circulation"},{"key":"2207_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1681\/ASN.2014040393","volume":"26","author":"KR Saab","year":"2015","unstructured":"Saab KR, Kendrick J, Yracheta JM, Lanaspa MA, Pollard M, Johnson RJ. New insights on the risk for cardiovascular disease in African Americans: the role of added sugars. J Am Soc Nephrol. 2015;26:247\u201357.","journal-title":"J Am Soc Nephrol"},{"key":"2207_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2105\/AJPH.2004.048165","volume":"95","author":"AJ Thomas","year":"2005","unstructured":"Thomas AJ, Eberly LE, Davey Smith G, Neaton JD, Stamler J. Race\/ethnicity, income, major risk factors, and cardiovascular disease mortality. Am J Public Health. 2005;95:1417\u201323.","journal-title":"Am J Public Health"},{"key":"2207_CR5","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1017\/S0954579418000937","volume":"30","author":"MK Lei","year":"2018","unstructured":"Lei MK, Beach SRH, Simons RL. Biological embedding of neighborhood disadvantage and collective efficacy: influences on chronic illness via accelerated cardiometabolic age. Dev Psychopathol. 2018;30:1797\u2013815.","journal-title":"Dev Psychopathol"},{"key":"2207_CR6","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.2105\/AJPH.2018.304864","volume":"109","author":"SP Bagby","year":"2019","unstructured":"Bagby SP, Martin D, Chung ST, Rajapakse N. From the outside in: biological mechanisms linking social and environmental exposures to chronic disease and to health disparities. Am J Public Health. 2019;109:S56\u201363.","journal-title":"Am J Public Health"},{"key":"2207_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","volume":"13","author":"A Gistera","year":"2017","unstructured":"Gistera A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368.","journal-title":"Nat Rev Nephrol"},{"key":"2207_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med"},{"key":"2207_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2013.11.007","volume":"45","author":"L Chavez-Sanchez","year":"2014","unstructured":"Chavez-Sanchez L, Espinosa-Luna JE, Chavez-Rueda K, Legorreta-Haquet MV, Montoya-Diaz E, Blanco-Favela F. Innate immune system cells in atherosclerosis. Arch Med Res. 2014;45:1\u201314.","journal-title":"Arch Med Res"},{"key":"2207_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1358\/dot.2001.37.3.614852","volume":"37","author":"WA Boisvert","year":"2001","unstructured":"Boisvert WA. The participation of inflammatory cells in atherosclerosis. Drugs Today (Barc). 2001;37:173\u20139.","journal-title":"Drugs Today (Barc)"},{"key":"2207_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","volume":"7","author":"KJ Woollard","year":"2010","unstructured":"Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7:77\u201386.","journal-title":"Nat Rev Cardiol"},{"key":"2207_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MOL.0000000000000302","volume":"27","author":"F Schaftenaar","year":"2016","unstructured":"Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27:209\u201315.","journal-title":"Curr Opin Lipidol"},{"key":"2207_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.12998\/wjcc.v3.i4.345","volume":"3","author":"F Ilhan","year":"2015","unstructured":"Ilhan F, Kalkanli ST. Atherosclerosis and the role of immune cells. World J Clin Cases. 2015;3:345\u201352.","journal-title":"World J Clin Cases"},{"key":"2207_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrcardio.2017.2","volume":"14","author":"GS Getz","year":"2017","unstructured":"Getz GS, Reardon CA. Natural killer T cells in atherosclerosis. Nat Rev Cardiol. 2017;14:304\u201314.","journal-title":"Nat Rev Cardiol"},{"key":"2207_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","volume":"120","author":"Y Doring","year":"2017","unstructured":"Doring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res. 2017;120:736\u201343.","journal-title":"Circ Res"},{"key":"2207_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/ATVBAHA.114.303564","volume":"35","author":"Y Doring","year":"2015","unstructured":"Doring Y, Drechsler M, Soehnlein O, Weber C. Neutrophils in atherosclerosis: from mice to man. Arterioscler Thromb Vasc Biol. 2015;35:288\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00424-017-1941-y","volume":"469","author":"C Cochain","year":"2017","unstructured":"Cochain C, Zernecke A. Macrophages in vascular inflammation and atherosclerosis. Pflugers Arch. 2017;469:485\u201399.","journal-title":"Pflugers Arch"},{"key":"2207_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00395-015-0491-8","volume":"110","author":"C Cochain","year":"2015","unstructured":"Cochain C, Zernecke A. Macrophages and immune cells in atherosclerosis: recent advances and novel concepts. Basic Res Cardiol. 2015;110:34.","journal-title":"Basic Res Cardiol"},{"key":"2207_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321.","journal-title":"N Engl J Med"},{"key":"2207_CR20","doi-asserted-by":"publisher","first-page":"e001926","DOI":"10.1161\/CIRCGEN.118.001926","volume":"11","author":"P Natarajan","year":"2018","unstructured":"Natarajan P, Jaiswal S, Kathiresan S. Clonal hematopoiesis: somatic mutations in blood cells and atherosclerosis. Circ Genom Precis Med. 2018;11:e001926.","journal-title":"Circ Genom Precis Med"},{"key":"2207_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","volume":"122","author":"JJ Fuster","year":"2018","unstructured":"Fuster JJ, Walsh K. Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease. Circ Res. 2018;122:523\u201332.","journal-title":"Circ Res"},{"key":"2207_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71:875\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"2207_CR23","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","volume":"70","author":"P Libby","year":"2017","unstructured":"Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70:2278\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"2207_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/ATVBAHA.114.303565","volume":"35","author":"I Hilgendorf","year":"2015","unstructured":"Hilgendorf I, Swirski FK, Robbins CS. Monocyte fate in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:272\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2015.09.006","volume":"168","author":"I Bonaccorsi","year":"2015","unstructured":"Bonaccorsi I, De Pasquale C, Campana S, Barberi C, Cavaliere R, Benedetto F, Ferlazzo G. Natural killer cells in the innate immunity network of atherosclerosis. Immunol Lett. 2015;168:51\u20137.","journal-title":"Immunol Lett"},{"key":"2207_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","volume":"116","author":"P Libby","year":"2015","unstructured":"Libby P, Hansson GK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015;116:307\u201311.","journal-title":"Circ Res"},{"key":"2207_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","volume":"110","author":"O Soehnlein","year":"2012","unstructured":"Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res. 2012;110:875\u201388.","journal-title":"Circ Res"},{"key":"2207_CR28","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000296915","volume":"2","author":"NA Braun","year":"2010","unstructured":"Braun NA, Covarrubias R, Major AS. Natural killer T cells and atherosclerosis: form and function meet pathogenesis. J Innate Immun. 2010;2:316\u201324.","journal-title":"J Innate Immun"},{"key":"2207_CR30","doi-asserted-by":"publisher","first-page":"e97179","DOI":"10.1172\/jci.insight.97179","volume":"3","author":"Y Baumer","year":"2018","unstructured":"Baumer Y, Ng Q, Sanda GE, Dey AK, Teague HL, Sorokin AV, Dagur PK, Silverman JI, Harrington CL, Rodante JA, et al. Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. JCI Insight. 2018;3:e97179.","journal-title":"JCI Insight"},{"key":"2207_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacbts.2018.10.008","volume":"4","author":"HL Teague","year":"2019","unstructured":"Teague HL, Varghese NJ, Tsoi LC, Dey AK, Garshick MS, Silverman JI, Baumer Y, Harrington CL, Stempinski E, Elnabawi YA, et al. Neutrophil subsets, platelets, and vascular disease in psoriasis. JACC Basic Transl Sci. 2019;4:1\u201314.","journal-title":"JACC Basic Transl Sci"},{"key":"2207_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41467-017-01186-z","volume":"8","author":"Y Baumer","year":"2017","unstructured":"Baumer Y, McCurdy S, Weatherby TM, Mehta NN, Halbherr S, Halbherr P, Yamazaki N, Boisvert WA. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun. 2017;8:1129.","journal-title":"Nat Commun"},{"key":"2207_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2016.11.017","volume":"256","author":"Y Baumer","year":"2017","unstructured":"Baumer Y, McCurdy S, Alcala M, Mehta N, Lee BH, Ginsberg MH, Boisvert WA. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. Atherosclerosis. 2017;256:105\u201314.","journal-title":"Atherosclerosis"},{"key":"2207_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41043-017-0114-0","volume":"36","author":"L Jahangiry","year":"2017","unstructured":"Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr. 2017;36:36.","journal-title":"J Health Popul Nutr"},{"key":"2207_CR35","first-page":"5","volume":"73","author":"PK Dagur","year":"2015","unstructured":"Dagur PK, McCoy JP Jr. Collection, storage, and preparation of human blood cells. Curr Protoc Cytom. 2015;73:5\u201316.","journal-title":"Curr Protoc Cytom"},{"key":"2207_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126:458\u201365.","journal-title":"Immunology"},{"key":"2207_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/ncpcardio1322","volume":"5","author":"K Musunuru","year":"2008","unstructured":"Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5:621\u201335.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2207_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1373\/clinchem.2008.109728","volume":"55","author":"S Mora","year":"2009","unstructured":"Mora S, Musunuru K, Blumenthal RS. The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem. 2009;55:219\u201328.","journal-title":"Clin Chem"},{"key":"2207_CR39","volume-title":"Clinical methods: the history, physical, and laboratory examinations","author":"MS Blumenreich","year":"1990","unstructured":"Blumenreich MS. The white blood cell and differential count. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths; 1990."},{"key":"2207_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/CIRCHEARTFAILURE.112.968073","volume":"6","author":"BJ Wrigley","year":"2013","unstructured":"Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail. 2013;6:127\u201335.","journal-title":"Circ Heart Fail"},{"key":"2207_CR41","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1161\/01.CIR.0000086897.15588.4B","volume":"108","author":"D Gregg","year":"2003","unstructured":"Gregg D, Goldschmidt-Clermont PJ. Cardiology patient page. Platelets and cardiovascular disease. Circulation. 2003;108:e88\u201390.","journal-title":"Circulation"},{"key":"2207_CR42","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/ndt\/gfg348","volume":"18","author":"N Ashman","year":"2003","unstructured":"Ashman N, Macey MG, Fan SL, Azam U, Yaqoob MM. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol Dial Transplant. 2003;18:2088\u201396.","journal-title":"Nephrol Dial Transplant"},{"key":"2207_CR43","doi-asserted-by":"publisher","first-page":"eaax0481","DOI":"10.1126\/scitranslmed.aax0481","volume":"11","author":"TJ Barrett","year":"2019","unstructured":"Barrett TJ, Schlegel M, Zhou F, Gorenchtein M, Bolstorff J, Moore KJ, Fisher EA, Berger JS. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci Transl Med. 2019;11:eaax0481.","journal-title":"Sci Transl Med"},{"key":"2207_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.7326\/0003-4819-146-7-200704030-00004","volume":"146","author":"MM Hsieh","year":"2007","unstructured":"Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007;146:486\u201392.","journal-title":"Ann Intern Med"},{"key":"2207_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jcp.49.8.664","volume":"49","author":"BJ Bain","year":"1996","unstructured":"Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996;49:664\u20136.","journal-title":"J Clin Pathol"},{"key":"2207_CR46","doi-asserted-by":"publisher","first-page":"62898","DOI":"10.18632\/oncotarget.11704","volume":"7","author":"R Kurupati","year":"2016","unstructured":"Kurupati R, Kossenkov A, Haut L, Kannan S, Xiang Z, Li Y, Doyle S, Liu Q, Schmader K, Showe L, Ertl H. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. 2016;7:62898\u2013911.","journal-title":"Oncotarget"},{"key":"2207_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.imlet.2013.03.004","volume":"152","author":"LJ Appleby","year":"2013","unstructured":"Appleby LJ, Nausch N, Midzi N, Mduluza T, Allen JE, Mutapi F. Sources of heterogeneity in human monocyte subsets. Immunol Lett. 2013;152:32\u201341.","journal-title":"Immunol Lett"},{"key":"2207_CR48","doi-asserted-by":"publisher","first-page":"39483","DOI":"10.1038\/srep39483","volume":"6","author":"M Wildgruber","year":"2016","unstructured":"Wildgruber M, Aschenbrenner T, Wendorff H, Czubba M, Glinzer A, Haller B, Schiemann M, Zimmermann A, Berger H, Eckstein HH, et al. The \u201cIntermediate\u201d CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans. Sci Rep. 2016;6:39483.","journal-title":"Sci Rep"},{"key":"2207_CR49","doi-asserted-by":"publisher","first-page":"e0149143","DOI":"10.1371\/journal.pone.0149143","volume":"11","author":"N Zungsontiporn","year":"2016","unstructured":"Zungsontiporn N, Tello RR, Zhang G, Mitchell BI, Budoff M, Kallianpur KJ, Nakamoto BK, Keating SM, Norris PJ, Ndhlovu LC, et al. Non-classical monocytes and monocyte chemoattractant protein-1 (MCP-1) correlate with coronary artery calcium progression in chronically HIV-1 infected adults on stable antiretroviral therapy. PLoS ONE. 2016;11:e0149143.","journal-title":"PLoS ONE"},{"key":"2207_CR50","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(01)01485-1","volume":"38","author":"MI Furman","year":"2001","unstructured":"Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL 3rd, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol. 2001;38:1002\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"2207_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2017.03.052","volume":"816","author":"GHM van Puijvelde","year":"2017","unstructured":"van Puijvelde GHM, Kuiper J. NKT cells in cardiovascular diseases. Eur J Pharmacol. 2017;816:47\u201357.","journal-title":"Eur J Pharmacol"},{"key":"2207_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/01.ATV.0000153046.59370.13","volume":"25","author":"AM Aslanian","year":"2005","unstructured":"Aslanian AM, Chapman HA, Charo IF. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2005;25:628\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/08820139.2017.1306866","volume":"46","author":"NR Jabir","year":"2017","unstructured":"Jabir NR, Firoz CK, Ahmed F, Kamal MA, Hindawi S, Damanhouri GA, Almehdar HA, Tabrez S. Reduction in CD16\/CD56 and CD16\/CD3\/CD56 natural killer cells in coronary artery disease. Immunol Invest. 2017;46:526\u201335.","journal-title":"Immunol Invest"},{"key":"2207_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijcard.2005.07.034","volume":"110","author":"ML Yen","year":"2006","unstructured":"Yen ML, Yang CY, Yen BL, Ho YL, Cheng WC, Bai CH. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol. 2006;110:191\u20138.","journal-title":"Int J Cardiol"},{"key":"2207_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/cphy.c140074","volume":"5","author":"FW Lam","year":"2015","unstructured":"Lam FW, Vijayan KV, Rumbaut RE. Platelets and their interactions with other immune cells. Compr Physiol. 2015;5:1265\u201380.","journal-title":"Compr Physiol"},{"key":"2207_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.ATV.0000106320.40933.E5","volume":"24","author":"Martins P da Costa","year":"2004","unstructured":"da Costa Martins P, van den Berk N, Ulfman LH, Koenderman L, Hordijk PL, Zwaginga JJ. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol. 2004;24:193\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR57","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1538-7836.2006.01817.x","volume":"4","author":"N Li","year":"2006","unstructured":"Li N, Ji Q, Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost. 2006;4:874\u201381.","journal-title":"J Thromb Haemost"},{"key":"2207_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbrc.2005.01.146","volume":"329","author":"KC Ahn","year":"2005","unstructured":"Ahn KC, Jun AJ, Pawar P, Jadhav S, Napier S, McCarty OJ, Konstantopoulos K. Preferential binding of platelets to monocytes over neutrophils under flow. Biochem Biophys Res Commun. 2005;329:345\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"2207_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.115.019475","volume":"133","author":"SH Shah","year":"2016","unstructured":"Shah SH, Arnett D, Houser SR, Ginsburg GS, MacRae C, Mital S, Loscalzo J, Hall JL. Opportunities for the cardiovascular community in the precision medicine initiative. Circulation. 2016;133:226\u201331.","journal-title":"Circulation"},{"key":"2207_CR60","first-page":"11S","volume":"93","author":"WM Byrd","year":"2001","unstructured":"Byrd WM, Clayton LA. Race, medicine, and health care in the United States: a historical survey. J Natl Med Assoc. 2001;93:11S\u201334S.","journal-title":"J Natl Med Assoc"},{"key":"2207_CR61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol. 2012;12:191\u2013200.","journal-title":"Nat Rev Immunol"},{"key":"2207_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury A, Pluckthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518:27\u20139.","journal-title":"Nature"},{"key":"2207_CR63","doi-asserted-by":"publisher","first-page":"e65485","DOI":"10.1371\/journal.pone.0065485","volume":"8","author":"F Villanova","year":"2013","unstructured":"Villanova F, Di Meglio P, Inokuma M, Aghaeepour N, Perucha E, Mollon J, Nomura L, Hernandez-Fuentes M, Cope A, Prevost AT, et al. Integration of lyoplate based flow cytometry and computational analysis for standardized immunological biomarker discovery. PLoS ONE. 2013;8:e65485.","journal-title":"PLoS ONE"},{"key":"2207_CR64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/521274a","volume":"521","author":"M Baker","year":"2015","unstructured":"Baker M. Reproducibility crisis: blame it on the antibodies. Nature. 2015;521:274\u20136.","journal-title":"Nature"},{"key":"2207_CR65","first-page":"2053","volume":"62","author":"N Abramson","year":"2000","unstructured":"Abramson N, Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician. 2000;62:2053\u201360.","journal-title":"Am Fam Physician"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-020-02207-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:15:09Z","timestamp":1610756109000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02207-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02207-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study approval was obtained from the Institutional Review Board (IRB) at National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) in accordance with the principles of Declaration of Helsinki. Data for all study participants were obtained under the IRB approved clinical trials NCT01143454, NCT03288207, and NCT00001846. All study participants in the cohort provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript does not contain data or images from an individual person and is therefore not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}